Patients‘ characteristics
All 100 patients were enrolled in the study according to specific
inclusion and exclusion criteria. The average number of recorded points
was 4580±1035 (interquartile range; IQR 2466-7711). Of the 100 patients,
the ACZ was observed in 95 patients (95%), and the ACZ was linearly
distributed (Figure 1 ). To investigate the characteristics of
patients with ACZ, we divided all patients into two groups as follows:
non-ACZ group (n=5) and ACZ group (n=95). Patients‘ characteristics are
listed in Table 1 . All
five patients in the non-ACZ group had PAF. Patients in the ACZ group
had significantly elevated body mass index (BMI), higher prevalence of
hypertension, and larger LA diameter/BSA than those in the non-ACZ
group. Baseline medication therapy and the other TTE findings did not
differ between the non-ACZ group and the ACZ group.